Citius Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q2 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2020 to Q2 2024.
  • Citius Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -44.7 %, a 44% decline year-over-year.
  • Citius Pharmaceuticals, Inc. annual Return On Equity for 2023 was -34 %, a 15.4% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Return On Equity for 2022 was -29.5 %, a 34.7% decline from 2021.
  • Citius Pharmaceuticals, Inc. annual Return On Equity for 2021 was -21.9 %, a 65.5% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -44.7 -13.6 -44% Apr 1, 2024 Jun 30, 2024
Q1 2024 -40.8 -10.3 -33.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -41.6 -15.8 -60.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -34 -4.55 -15.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -31 -5.81 -23.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -30.5 -8.97 -41.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -25.9 -7.32 -39.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29.5 -7.6 -34.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.2 +2.35 +8.53% Apr 1, 2022 Jun 30, 2022
Q1 2022 -21.5 +17.9 +45.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -18.6 +56.8 +75.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -21.9 +41.5 +65.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -27.6 +38 +58% Apr 1, 2021 Jun 30, 2021
Q1 2021 -39.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 -75.4 Oct 1, 2020 Dec 31, 2020
Q3 2020 -63.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 -65.5 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.